Immunotherapy

The addition of nivolumab to ipilimumab significantly improved OS among adults with previously untreated advanced hepatocellular carcinoma, according to a release by the agent’s manufacturer.

A novel chimeric antigen receptor T-cell therapy produced significant tumor reductions in patients with glioblastoma, results from a phase 1 trial published in The New England Journal of Medicine showed.

A phase 2 trial conducted by researchers at The University of Texas MD Anderson Cancer Center demonstrated the safety and potential efficacy of neoadjuvant immunotherapy for patients with soft tissue sarcoma.

WASHINGTON — Adults with peanut allergy safely used toothpaste infused with peanut protein as oral mucosal immunotherapy, according to a poster presented at the American Academy of Allergy, Asthma & Immunology Annual Meeting.

SAN DIEGO — Actor William Shatner still vividly recalls the moment he learned a simple lump under his right ear, initially dismissed, was in fact cancer, and how concern from a caring physician likely saved his life.

Liquid biopsy could provide enhanced information about chimeric antigen receptor T-cell therapy compared with normally used DNA, RNA and protein assays, according to findings published in Journal for ImmunoTherapy of Cancer.

Gemcitabine and platinum chemotherapy administered after nephroureterectomy SIGNIFICSALTY improved OS among certain patients with upper tract urothelial carcinoma, updated results form a randomized phase 3 study showed.

Steven A. Rosenberg, MD, PhD, FAACR, will be awarded the 2024 American Association for Cancer Research Award for Lifetime Achievement in Cancer Research during the AACR Annual Meeting in San Diego.

To help individuals who undergo cancer treatment lead healthier lives, Stacyann Bailey, PhD, has one overarching professional mission — to prevent bones from breaking.

David J. Benjamin, MD, recently met with a patient who recalled the moment a previous physician had diagnosed him with cancer.